No Data
No Data
BTIG Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $12
LifeMD, Inc.'s (NASDAQ:LFMD) Top Owners Are Retail Investors With 45% Stake, While 38% Is Held by Institutions
B.Riley Financial Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $11
LifeMD, Inc. 8.875% CUM PFD A Declares $0.5547 Dividend
Press Release: LifeMD(R) Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Express News | LifeMD Announces Major Enhancements to Its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options